Intervention Review

Vitamin E for neuroleptic-induced tardive dyskinesia

  1. Karla Soares-Weiser1,*,
  2. Nicola Maayan1,
  3. John McGrath2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 16 FEB 2011

Assessed as up-to-date: 19 JUL 2010

DOI: 10.1002/14651858.CD000209.pub2

How to Cite

Soares-Weiser K, Maayan N, McGrath J. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD000209. DOI: 10.1002/14651858.CD000209.pub2.

Author Information

  1. 1

    Enhance Reviews Ltd, Wantage, UK

  2. 2

    Queensland Brain Institute, Queensland Centre for Mental Health Research, Brisbane, Queensland, Australia

*Karla Soares-Weiser, Enhance Reviews Ltd, Central Office, Cobweb Buildings, The Lane, Lyford, Wantage, OX12 0EE, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 FEB 2011


Cited in:


This article has been cited by:

  1. 1
    Therapie Psychischer Erkrankungen, 2014,


  2. 2
    Robert H. Howland, Drug Therapies for Tardive Dyskinesia: Part 2, Journal of Psychosocial Nursing and Mental Health Services, 2011, 49, 7, 17


  3. 3
    Anna Selva Olid, Dolors Ramírez i Tarruella, Dimelza Osorio, Antonio Jesús Blanco Carrasco, Ivan Solà, Vitamin E supplementation for adults with diabetes mellitus, The Cochrane Library,